Aberrant methylation of tissue factor pathway inhibitor-2 is a biomarker for HSIL and squamous cell carcinoma of the cervix

被引：0
|
作者：
Bin Yang [1 ]
Ji, Xin [1 ]
Scheidemantel, Thomas [1 ]
Abu Shahin, Fadi [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH USA
来源：
CANCER CYTOPATHOLOGY | 2007年 / 111卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PF7
引用
收藏
页码：349 / 350
页数：2
相关论文
共 50 条
  • [1] Promoter hypermethylation and silencing of tissue factor pathway inhibitor-2 in oral squamous cell carcinoma
    Lai, Yi-Hui
    He, Ru-Yin
    Chou, Jian-Liang
    Chan, Michael W-Y
    Li, Yu-Fen
    Tai, Chien-Kuo
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [2] Promoter hypermethylation and silencing of tissue factor pathway inhibitor-2 in oral squamous cell carcinoma
    Yi-Hui Lai
    Ru-Yin He
    Jian-Liang Chou
    Michael W-Y Chan
    Yu-Fen Li
    Chien-Kuo Tai
    Journal of Translational Medicine, 12
  • [3] Aberrant Methylation of Tissue Factor Pathway Inhibitor-2 is a Late Event During Cervical Carcinogenesis
    Ji, X.
    Scheidemantel, T.
    Yang, B.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06): : 601 - 601
  • [4] Tissue factor pathway inhibitor-2 induced hepatocellular carcinoma cell differentiation
    Li, Ziwei
    Xu, Yong
    Wang, Qin
    Xie, Changli
    Liu, Yincui
    Tu, Zhiguang
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2017, 24 (01) : 95 - 102
  • [5] Tissue factor pathway inhibitor-2 (TFPI-2) is a novel immunohistochemical biomarker in ovarian clear cell carcinoma
    Ota, Yukihide
    Koizume, Shiro
    Sato, Shinya
    Nakamura, Yoshiyasu
    Miyagi, Etsuko
    Miyagi, Yohei
    CANCER SCIENCE, 2021, 112 : 770 - 770
  • [6] TISSUE FACTOR PATHWAY INHIBITOR-2 AS A PROGNOSTIC FACTOR IN PANCREATIC CARCINOMA
    俞建雄
    袁静
    王春友
    Medical Bulletin of Shanghai Jiaotong University, 2013, 25 (01) : 12 - 18
  • [7] Tissue factor pathway inhibitor-2 gene methylation in carotid atherosclerotic plaques
    Zawadzki, C.
    Breyne, J.
    Chatelain, N.
    Delestre, M.
    Susen, S.
    Quesnel, B.
    Juthier, F.
    Jeanpierre, E.
    Azzaoui, R.
    Corseaux, D.
    Torpier, G.
    Staels, B.
    Van Belle, E.
    Jude, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 598 - 598
  • [8] Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy
    Sun, Feng-Kai
    Sun, Qi
    Fan, Yu-Chen
    Gao, Shuai
    Zhao, Jing
    Li, Feng
    Jia, Yi-Bin
    Liu, Chuan
    Wang, Li-Yuan
    Li, Xin-You
    Ji, Xiang-Fen
    Wang, Kai
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (02) : 484 - 492
  • [9] Tissue Factor Pathway Inhibitor-2 Silencing Promotes Hepatocellular Carcinoma Cell Invasion In Vitro
    Zhu, Bin
    Zhang, Ping
    Zeng, Ping
    Huang, Zhen
    Dong, Ting-Fang
    Gui, Yong-Kun
    Zhang, Guang-Wen
    ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2013, 296 (11): : 1708 - 1716
  • [10] Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma
    Jiang, PeiHong
    Watanabe, Hiroyuki
    Okada, Gensaku
    Ohtsubo, Koushiro
    Mouri, Hisatsugu
    Tsuchiyama, Tomoya
    Yao, Fan
    Sawabu, Norio
    CANCER SCIENCE, 2006, 97 (11) : 1267 - 1273
12345